Targeted proteomics for validation of biomarkers in early psychosis

Biological Psychiatry

Volumn 76, Issue 6, 2014, Pages

  English, Jane A ^a   Wynne, Kieran ^b   Cagney, Gerard ^b   Cotter, David R ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

HUMAN; IMMUNE RESPONSE; LETTER; LIQUID CHROMATOGRAPHY; MASS SCREENING; MASS SPECTROMETER; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; PSYCHOSIS; SCHIZOPHRENIA; TANDEM MASS SPECTROMETRY; PSYCHOTIC DISORDERS;

BIOLOGICAL MARKERS; HUMANS; MASS SPECTROMETRY; PROTEOMICS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84907598303     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.11.016     Document Type: Letter

References (29)

1. T.K. Larsen, I. Melle, B. Auestad, U. Haahr, I. Joa, and J.O. Johannessen et al. Early detection of psychosis: positive effects on 5-year outcome Psychol Med 41 2011 1461 1469
2. E.F. Walker, H.D. Trotman, B.D. Pearce, J. Addington, K.S. Cadenhead, and B.A. Cornblatt et al. Cortisol levels and risk for psychosis: Initial findings from the North American prodrome longitudinal study Biol Psychiatry 74 2013 410 417
3. E. Schwarz, P.C. Guest, H. Rahmoune, L.W. Harris, L. Wang, and F.M. Leweke et al. Identification of a biological signature for schizophrenia in serum Mol Psychiatry 17 2011 494 502
4. Y. Levin, L. Wang, E. Schwarz, D. Koethe, F.M. Leweke, and S. Bahn Global proteomic profiling reveals altered proteomic signature in schizophrenia serum Mol Psychiatry 15 2010 1088 1100
5. S. Bahn, R. Noll, A. Barnes, E. Schwarz, and P.C. Guest Challenges of introducing new biomarker products for neuropsychiatric disorders into the market Int Rev Neurobiol 101 2011 299 327
6. J.A. English, K. Pennington, M.J. Dunn, and D.R. Cotter The neuroproteomics of schizophrenia Biol Psychiatry 69 2011 163 172
7. M. Focking, P. Dicker, J.A. English, K.O. Schubert, M.J. Dunn, and D.R. Cotter Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3 Arch Gen Psychiatry 68 2011 477 488
8. K. Pennington, C.L. Beasley, P. Dicker, A. Fagan, J. English, and C.M. Pariante et al. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder Mol Psychiatry 13 2008 1102 1117
9. A.T. Behan, C. Byrne, M.J. Dunn, G. Cagney, and D.R. Cotter Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression Mol Psychiatry 14 2009 601 613
10. S. Prabakaran, J.E. Swatton, M.M. Ryan, S.J. Huffaker, J.T. Huang, and J.L. Griffin et al. Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress Mol Psychiatry 9 684-697 2004 643
11. M.K. Chan, T.M. Tsang, L.W. Harris, P.C. Guest, E. Holmes, and S. Bahn Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients Mol Psychiatry 16 2011 1189 1202
12. E. Schwarz, R. Izmailov, M. Spain, A. Barnes, J.P. Mapes, and P.C. Guest et al. Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia Biomark Insights 5 2010 39 47
13. P.M. Bossuyt The thin line between hope and hype in biomarker research JAMA 305 2011 2229 2230
14. M.S. Pepe, Z. Feng, H. Janes, P.M. Bossuyt, and J.D. Potter Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: Standards for study design J Natl Cancer Inst 100 2008 1432 1438
15. J.P. Ioannidis, and O.A. Panagiotou Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses JAMA 305 2011 2200 2210
16. T.A. Addona, X. Shi, H. Keshishian, D.R. Mani, M. Burgess, and M.A. Gillette et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease Nat Biotechnol 29 2011 635 643
17. J.R. Whiteaker, C. Lin, J. Kennedy, L. Hou, M. Trute, and I. Sokal et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma Nat Biotechnol 29 2011 625 634
18. V. Marx Targeted proteomics Nat Methods 10 2013 19 22
19. B. Schilling, M.J. Rardin, B.X. MacLean, A.M. Zawadzka, B.E. Frewen, and M.P. Cusack et al. Platform-independent and label-free quantitation of proteomic data using MS1 extracted ion chromatograms in skyline: Application to protein acetylation and phosphorylation Mol Cell Proteomics 11 2012 202 214
20. M.J. Rardin, J.C. Newman, J.M. Held, M.P. Cusack, D.J. Sorensen, and B. Li et al. Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways Proc Natl Acad Sci U S A 110 2013 6601 6606
21. J.D. Jaffe, H. Keshishian, B. Chang, T.A. Addona, M.A. Gillette, and S.A. Carr Accurate inclusion mass screening: A bridge from unbiased discovery to targeted assay development for biomarker verification Mol Cell Proteomics 7 2008 1952 1962
22. J.D. Jaffe, Y. Wang, H.M. Chan, J. Zhang, R. Huether, and G.V. Kryukov et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia Nature Genet 45 2013 1386 1391
23. B. MacLean, D.M. Tomazela, N. Shulman, M. Chambers, G.L. Finney, and B. Frewen et al. Skyline: An open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 26 2010 966 968
24. J.A. English, P. Dicker, M. Focking, M.J. Dunn, and D.R. Cotter 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease Proteomics 9 2009 3368 3382
25. J. English, K. Wynne, G. Cagney, and D.R. Cotter Proteomic analysis of the corpus callosum reveals alteration of the glycolysis protein pathway and further implicates CME in Schizophrenia Schizophr Res 136 2012 S155
26. D. Martins-De-Souza, E. Dias-Neto, A. Schmitt, P. Falkai, P. Gormanns, and G. Maccarrone et al. Proteome analysis of schizophrenia brain tissue World J Biol Psychiatry 11 2010 110 120
27. E. Bellei, S. Bergamini, E. Monari, L.I. Fantoni, A. Cuoghi, and T. Ozben et al. High-abundance proteins depletion for serum proteomic analysis: Concomitant removal of non-targeted proteins Amino Acids 40 2011 145 156
28. J.A. English, A. Harauma, M. Föcking, K. Wynne, C. Scaife, and G. Cagney et al. Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus Front Genet 4 2013 208
29. T. Farrah, E.W. Deutsch, G.S. Omenn, D.S. Campbell, Z. Sun, and J.A. Bletz et al. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas Mol Cell Proteomics 10 M110 2011 006353